During the past decade, Charite - UB - CVK - Medizinische Klinik conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Charite - UB - CVK - Medizinische Klinik" are "Gastro-enteropancreatic Neuroendocrine Tumor" (1 trials), "Pyruvate Kinase Deficiency" (1 trials), "Transfusion-dependent Alpha-Thalassemia" (1 trials) and "Transfusion-dependent Beta-Thalassemia" (1 trials). Many other conditions were trialed in "Charite - UB - CVK - Medizinische Klinik" in a lesser frequency.

Most popular intervention types in "Charite - UB - CVK - Medizinische Klinik" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "AG-348" (1 trials), "CAM2029" (1 trials), "Lanreotide ATG" (1 trials), "Mitapivat" (1 trials) and "Octreotide LAR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charite - UB - CVK - Medizinische Klinik" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Charite - UB - CVK - Medizinische Klinik". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Charite - UB - CVK - Medizinische Klinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Charite - UB - CVK - Medizinische Klinik, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".